acalabrutinib

Details

Key Milestones2
Call for patient/clinician input open13-May-25
Call for patient/clinician input closed07-Jul-25
Submission received24-Jun-25
Submission accepted09-Jul-25
Review initiated10-Jul-25
Draft CADTH review report(s) provided to sponsor for comment24-Sep-25
Deadline for sponsors comments06-Oct-25
CDA-AMC review report(s) and responses to comments provided to sponsor30-Oct-25
Expert committee meeting (initial)12-Nov-25
Draft recommendation issued to sponsorNovember 24, 2025
To
November 26, 2025
Draft recommendation posted for stakeholder feedback04-Dec-25
End of feedback period18-Dec-25
Deadline for sponsor to submit redaction requests on draft CADTH review report(s)12-Nov-25